• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].

作者信息

Beloev I, Tomov I, Elenkova A, Terzieva L

出版信息

Vutr Boles. 1982;21(3):62-9.

PMID:6810552
Abstract

In 30 patients with a grave form of ischemic heart disease--unstable angina pectoris, peroral treatment with molsidomin (Corvaton) was carried out in a dose I table of 20 mg, three times daily, in the course of 33 days at an average. The incidence, intensity and duration of stenocardiac paroxysms were followed up as well as the nitroglycerine need- and electrocardiographic changes. The main hemodynamic indices, prior to and post treatment, were also determined. The stenocardiac paroxysms were established to disappear after molsidomin treatment in 30 per cent of the cases as well as reduction of anginose symptomatics in more than 50 per cent in 50 per cent of the patients, reduction of stenocardiac symptomatics to 50 per cent in 3.3 per cent of the cases and no effect in 16.7 per cent of the patients. The hemodynamic molsidomin effect was conditioned by the increase of the volume of the venous vascular system, due to which the venous flow to the heart was diminished--a reduction of the overloaded myocardium and its oxygen needs occurred.

摘要

相似文献

1
[Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
Vutr Boles. 1982;21(3):62-9.
2
[Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].[新型血管扩张剂莫西赛利治疗心绞痛的测力计研究:与β受体阻滞剂联合应用的价值]
Arch Mal Coeur Vaiss. 1981 Apr;74(4):463-71.
3
[Anti-ischemic effect of 8 mg molsidomin in retard form].8毫克缓释形式的吗多明的抗缺血作用
Herz. 1984 Dec;9(6):346-52.
4
[Effectiveness of using corvaton on patients with unstable stenocardia].
Vrach Delo. 1984 Nov(11):18-21.
5
Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.喷布洛尔与吗多明在心绞痛中的协同作用。一项双盲运动试验。
Eur J Clin Pharmacol. 1984;27(1):1-5.
6
[Corvaton in the ambulatory treatment of patients with angina pectoris].[可伐他汀用于心绞痛患者的门诊治疗]
Klin Med (Mosk). 1984 Oct;62(10):39-40.
7
[Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].基于肺活量计自行车测力计指标和中心血流动力学指标,观察奥布西丹、考瓦通和可立弗治疗心绞痛患者的疗效
Vrach Delo. 1985 Aug(8):19-21.
8
[Molsidomine in the long-term treatment of angina pectoris].[莫西多明在心绞痛长期治疗中的应用]
Herz. 1982 Oct;7(5):307-16.
9
Molsidomine in the treatment of patients with angina pectoris.莫西多明治疗心绞痛患者。
N Engl J Med. 1980 Jan 3;302(1):1-6. doi: 10.1056/NEJM198001033020101.
10
[Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].[莫西多明在冠心病患者中的作用持续时间及剂量反应关系]
Z Kardiol. 1984 Oct;73(10):613-22.